StockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Get Free Report) in a note issued to investors on Monday. The brokerage set a “sell” rating on the medical research company’s stock.
OpGen Stock Up 2.5 %
Shares of OPGN opened at $0.61 on Monday. The business has a 50-day simple moving average of $0.57 and a two-hundred day simple moving average of $0.51. The stock has a market cap of $7.74 million, a price-to-earnings ratio of -0.09 and a beta of -0.71. OpGen has a 52 week low of $0.17 and a 52 week high of $3.84.
About OpGen
Featured Stories
- Five stocks we like better than OpGen
- What is the S&P/TSX Index?
- Charles Schwab Fortifies its Uptrend on EPS Beat
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Lockheed Martin Stock Aims for a Fresh All-Time High
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.